tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRSP Stock Latest News

Crispr Therapeutics price target lowered to $80 from $86 at Citizens
The FlyCrispr Therapeutics price target lowered to $80 from $86 at Citizens
1d ago
CRSP
Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
PremiumMarket News
Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
1d ago
TER
ARKQ
Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics today
1d ago
CRSP
Cathie Wood’s ARK Investment buys 120K shares of Crispr Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 120K shares of Crispr Therapeutics today
2d ago
CRSP
Crispr Therapeutics price target lowered to $89 from $90 at BofA
PremiumThe Fly
Crispr Therapeutics price target lowered to $89 from $90 at BofA
9d ago
CRSP
CRISPR Therapeutics Highlights Pipeline Advances in Gene-Edited Therapies
PremiumCompany AnnouncementsCRISPR Therapeutics Highlights Pipeline Advances in Gene-Edited Therapies
19d ago
8K
CRSP
Crispr Therapeutics highlights anticipated 2026 milestones
Premium
The Fly
Crispr Therapeutics highlights anticipated 2026 milestones
19d ago
CRSP
Crispr Therapeutics says Casgevy exceeded $100M in revenue in 2025
Premium
The Fly
Crispr Therapeutics says Casgevy exceeded $100M in revenue in 2025
19d ago
CRSP
Crispr Therapeutics price target lowered to $90 from $93 at BofA
PremiumThe Fly
Crispr Therapeutics price target lowered to $90 from $93 at BofA
25d ago
CRSP
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026?
PremiumMarket News
Cathie Wood’s ARK Funds Had ‘One Heck of a Year’ — What’s Next for 2026?
27d ago
TEM
ARKF
Cathie Wood’s ARK Adds to CRISPR Stock — Here’s What Else It Traded This Week
PremiumMarket News
Cathie Wood’s ARK Adds to CRISPR Stock — Here’s What Else It Traded This Week
1M ago
WRD
ACHR
Cathie Wood Adds to WeRide (WRD) and CRISPR, Trims Ibotta (IBTA) in Holiday Trades
PremiumMarket News
Cathie Wood Adds to WeRide (WRD) and CRISPR, Trims Ibotta (IBTA) in Holiday Trades
1M ago
WRD
CRSP
Cathie Wood’s Christmas Trades: ARK Invest Bets on WeRide and CRISPR
PremiumMarket NewsCathie Wood’s Christmas Trades: ARK Invest Bets on WeRide and CRISPR
1M ago
WRD
CRSP
Early but Compelling CTX112 Data Underpin Buy Rating and $80 Target for CRISPR Therapeutics
Premium
Ratings
Early but Compelling CTX112 Data Underpin Buy Rating and $80 Target for CRISPR Therapeutics
1M ago
CRSP
Buy Rating on CRISPR Therapeutics Driven by Promising zugo‑cel Data, Expanding Gene-Editing Pipeline, and Favorable Long-Term Risk–Reward Profile
Premium
Ratings
Buy Rating on CRISPR Therapeutics Driven by Promising zugo‑cel Data, Expanding Gene-Editing Pipeline, and Favorable Long-Term Risk–Reward Profile
1M ago
CRSP
CRISPR Therapeutics: Early Autoimmune Promise, Best-in-Class Oncology Data, and Eli Lilly Partnership Support Buy Rating
PremiumRatings
CRISPR Therapeutics: Early Autoimmune Promise, Best-in-Class Oncology Data, and Eli Lilly Partnership Support Buy Rating
1M ago
CRSP
Crispr Therapeutics provides updates on zugo-cel
PremiumThe Fly
Crispr Therapeutics provides updates on zugo-cel
1M ago
CRSP
Buy Rating for Crispr Therapeutics AG: Pediatric Market Potential and Long-term Growth Opportunities
PremiumRatings
Buy Rating for Crispr Therapeutics AG: Pediatric Market Potential and Long-term Growth Opportunities
2M ago
CRSP
Crispr Therapeutics AG: Stock Surge Amid Challenges
PremiumWeekend Updates
Crispr Therapeutics AG: Stock Surge Amid Challenges
2M ago
CRSP
ARKB, HOOD, SHOP, WRD: Cathie Wood Expands Crypto and AI Bets, Trims Stakes in Roku and GitLab (GTLB) Stocks
PremiumMarket NewsARKB, HOOD, SHOP, WRD: Cathie Wood Expands Crypto and AI Bets, Trims Stakes in Roku and GitLab (GTLB) Stocks
2M ago
KDK
SYM
Crispr Therapeutics rumor highlighted in Betaville blog
Premium
The Fly
Crispr Therapeutics rumor highlighted in Betaville blog
2M ago
CRSP
Crispr Therapeutics price target lowered to $74 from $82 at Chardan
Premium
The Fly
Crispr Therapeutics price target lowered to $74 from $82 at Chardan
2M ago
CRSP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >